CNS Disorders  >>  methylprednisolone oral 
Welcome,         Profile    Billing    Logout  

8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylprednisolone oral / Generic mfg.
ACTRN12605000657628: A Multi-Centre, Open label Study to Investigate the Recovery of Interferon-b Efficacy in Relapsing-Remitting Multiple Sclerosis Patients with Neutralising IFN-b Antibodies and Reduced Bioavailability.

Recruiting
4
20
 
Biogen Idec Australia Pty Ltd, Biogen Idec Australia Pty Ltd
Relapsing-remitting Multiple Sclerosis
 
 
NTZ2TTY, NCT02769689: Methylprednisolone During the Switch Between Natalizumab and Fingolimod

Recruiting
4
56
Europe
Methylprednisolone, Placebo, natalizumab (NTZ), fingolimob (FTY)
University Hospital, Clermont-Ferrand
Multiple Sclerosis
06/24
07/24
DanNORMS, NCT04688788: Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Active, not recruiting
3
600
Europe
Rituximab, Ruxience, Rixathon® or other biosimilar rituximab, Ocrelizumab, Ocrevus, Fexofenadine, Paracetamol, Methylprednisolone
Rigshospitalet, Denmark, Odense University Hospital, Aarhus University Hospital, Aalborg University Hospital, Herlev Hospital, Hillerod Hospital, Denmark, Kolding Sygehus, Gødstrup Hospital, Hvidovre University Hospital, Hospital of South West Jutland, Esbjerg, Denmark, GCP unit, Copenhagen University Hospital, GCP-unit at Aarhus University Hospital, Aarhus, Denmark, Hospital of Southern Jutland, Sønderborg, Denmark, Hospital of Central Denmark Region, Viborg, Denmark, Danske Regioner, Hospital of Southern Jutland, Aabenraa, Denmark, Sanquin Research & Blood Bank Divisions
Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis
05/26
05/28
IMPACT-2, NCT06215261: An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD

Not yet recruiting
2
79
RoW
Methylone, Placebo
Transcend Therapeutics
Post Traumatic Stress Disorder
12/25
12/25
IMPACT-EXT, NCT06237426: An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD

Enrolling by invitation
2
150
Europe
Methylone
Transcend Therapeutics
Post Traumatic Stress Disorder
05/27
05/27
IMPACT-1, NCT05741710: A Study to Assess the Use of Methylone in the Treatment of PTSD

Recruiting
1/2
79
Europe
Methylone, Placebo
Transcend Therapeutics
Post Traumatic Stress Disorder
12/24
12/24
NCT06303648: A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects

Recruiting
1
24
RoW
Methylone
Transcend Therapeutics
Post Traumatic Stress Disorder
05/24
05/24
ChiCTR2300075076: The effect of combined low-dose methylprednisolone on neurological function and hemodynamics in patients with acute cerebral infarction combined with rheumatoid arthriti

Not yet recruiting
N/A
100
 
oral aspirin tablets (100mg once a day), Clopidogrel (75mg once a day), Atorvastatin calcium tablets (20mg once a day); ;Oral administration of methylprednisolone tablets (4mg once per day) on the basis of the control group
Xi'an Fifth Hospital; Xi'an Fifth Hospital, Scientific Research Project of Shaanxi Administration of Traditional Chinese Medicine
Cerebrovascular disease
 
 

Download Options